Our findings highlight the oncogenic and UPR signaling-suppressive roles of LINP1 in cSCC and emphasize a novel regulatory mechanism to constrain UPR signaling and the following apoptosis, which may provide novel intervention targets for designing new therapeutic modality of cSCC. The gene discussed is LINP1; the disease is skin squamous cell carcinoma.